Managing the intersection of cancer therapies and cardiovascular health, cardio-oncology has become an essential focus for healthcare providers. Treatments like chemotherapy and immunotherapy, while critical for combating cancer, can strain the heart and lead to conditions such as cardiomyopathy or arrhythmias. To address this, specialists collaborate to develop screening tools that predict risks and implement heart-protective strategies. Imaging techniques, advanced echocardiography, and biomarkers enable early detection of cardiotoxicity, ensuring timely interventions. By prioritizing the balance between effective cancer treatment and heart health, cardio-oncology aims to safeguard patients' quality of life during and beyond their cancer journey.
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile